Front Barnett Associates LLC Abb Vie Inc. Transaction History

Front Barnett Associates LLC

$833 Million
Q3 2023

A detailed history of Front Barnett Associates LLC transactions in Abb Vie Inc. stock. As of the latest transaction made, Front Barnett Associates LLC holds 6,394 shares of ABBV stock, worth $1.17 Million. This represents 0.11% of its overall portfolio holdings.

Number of Shares

6,394

Previous 6,910 7.47%

Holding current value

$1.17 Million

Previous $931,000 2.36%

% of portfolio

0.11%

Previous 0.11%

20 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q3 2023 Nov 13, 2023	SELL	$133.59 - $154.65 $68,932 - $79,799	-516 Reduced 7.47%	6,394 $953,000
Q2 2023 Aug 11, 2023	SELL	$132.51 - $164.9 $5,962 - $7,420	-45 Reduced 0.65%	6,910 $931,000
Q1 2023 May 08, 2023	SELL	$144.61 - $166.54 $867 - $999	-6 Reduced 0.09%	6,955 $1.11 Million
Q3 2022 Nov 07, 2022	SELL	$134.21 - $153.93 $1.22 Million - $1.4 Million	-9,108 Reduced 56.68%	6,961 $934,000
Q2 2022 Aug 12, 2022	BUY	$137.62 - $174.96 $1.3 Million - $1.65 Million	9,433 Added 142.15%	16,069 $2.46 Million
Q1 2022 May 11, 2022	BUY	$131.98 - $163.75 $791 - $982	6 Added 0.09%	6,636 $1.08 Million
Q4 2021 Feb 08, 2022	SELL	$107.43 - $135.93 $10,743 - $13,593	-100 Reduced 1.49%	6,630 $898,000
Q3 2021 Nov 04, 2021	SELL	$106.4 - $120.78 $49,582 - $56,283	-466 Reduced 6.48%	6,730 $726,000
Q2 2020 Aug 04, 2020	SELL	$73.37 - $98.18 $146 - $196	-2 Reduced 0.03%	7,196 $707,000
Q1 2020 May 14, 2020	BUY	$64.5 - $97.79 $86,107 - $130,549	1,335 Added 22.77%	7,198 $548,000
Q4 2019 Feb 12, 2020	SELL	$72.13 - $90.25 $144 - $180	-2 Reduced 0.03%	5,863 $519,000
Q3 2019 Nov 04, 2019	SELL	$62.98 - $75.72 $9,132 - $10,979	-145 Reduced 2.41%	5,865 $444,000
Q2 2019 Aug 06, 2019	SELL	$65.7 - $83.98 $71,744 - $91,706	-1,092 Reduced 15.38%	6,010 $437,000
Q1 2019 May 07, 2019	SELL	$77.14 - $90.79 $5,476 - $6,446	-71 Reduced 0.99%	7,102 $572,000
Q4 2018 Feb 07, 2019	SELL	$77.85 - $96.01 $20,241 - $24,962	-260 Reduced 3.5%	7,173 $661,000
Q3 2018 Nov 06, 2018	SELL	$88.91 - $98.84 $9,335 - $10,378	-105 Reduced 1.39%	7,433 $703,000
Q2 2018 Aug 08, 2018	SELL	$89.78 - $106.23 $59,254 - $70,111	-660 Reduced 8.05%	7,538 $698,000
Q1 2018 May 07, 2018	SELL	$92.01 - $123.21 $8,280 - $11,088	-90 Reduced 1.09%	8,198 $776,000
Q4 2017 Feb 07, 2018	SELL	$89.56 - $98.21 $24,629 - $27,007	-275 Reduced 3.21%	8,288 $802,000
Q3 2017 Nov 07, 2017	BUY	$69.85 - $89.22 $598,125 - $763,990	8,563	8,563 $761,000

Others Institutions Holding ABBV

# of Institutions

3,849

Shares Held

1.25B

Call Options Held

16.8M

Put Options Held

12.2M

View Full List

About AbbVie Inc.

Ticker ABBV
Exchange NYSE
Sector Healthcare
Industry Drug Manufacturers—General
Shares Outstandng 1,768,099,968
Market Cap $324B
Description
AbbVie Inc. discovers, develops, manufactures, and sells pharmaceuticals in the worldwide. The company offers HUMIRA, a therapy administered as an injection for autoimmune and intestinal Behçet's diseases; SKYRIZI to treat moderate to severe plaque psoriasis in adults; RINVOQ, a JAK inhibitor for the treatment of moderate to severe active rheuma...

More about ABBV

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Front Barnett Associates LLC, based on Form 13F filings with the SEC.

News

Stay updated on Front Barnett Associates LLC with notifications on news.

Account

Front Barnett Associates LLC Abb Vie Inc. Transaction History